Pfizer

Page 2 of 37

A white sign featuring the Pfizer logo
Health

GSK, Pfizer RSV shots must warn about rare paralysis risk

By
January 8, 2025
Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
Health

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

By
January 3, 2025
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
Commentary

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

By Jeffrey Sonnenfeld and Steven Tian
October 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
Health

Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination

By
October 22, 2024
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Commentary

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

By Jeffrey Sonnenfeld and Steven Tian
October 10, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
Finance

Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs

By
October 7, 2024
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.

RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine

By
October 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
Health

COVID sickens older adults most severely, but less than half say they’ll get the new vaccine

By
September 30, 2024
As of March 2024, the Centers for Disease Control and Prevention no longer advises a five-day isolation period when you test positive for COVID-19, but recommends taking other precautions once your symptoms subside.
Health

Got COVID? Here are the new 2024 isolation guidelines

By
September 27, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
Health

Could it be COVID? Here are the symptoms to watch out for in 2024

By
September 21, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
Health

New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge

By
August 29, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
Meet the ‘70-Year Club’: 49 companies have stayed at the top of the Fortune 500 for decades. Here are 4 keys to their longevity
Magazine

Meet the ‘70-Year Club’: 49 companies have stayed at the top of the Fortune 500 for decades. Here are 4 keys to their longevity

By Nicolas Rapp and Matthew Heimer
June 4, 2024
people walking outside La Defense area in Paris
Finance

France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive

By
May 13, 2024

Most Popular